Literature DB >> 16719794

Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and beta-catenin during oxidative stress.

Zhao Zhong Chong1, Faqi Li, Kenneth Maiese.   

Abstract

Metabotropic glutamate receptors are expressed throughout the nervous system, but their function as well as their ability to promote neuronal survival rests heavily upon the intracellular mechanisms governed by this family of G-proteins. In this regard, we examined one of the primary pathways that can oversee cell survival, namely protein kinase B (Akt1), and its functional integration with some of its substrates that may work in concert with group I metabotropic glutamate receptor (mGluRI) activation to protect primary hippocampal neurons during oxidative stress. We demonstrate that neuroprotection against free radical injury through mGluRI activation with DHPG requires the activation of Akt1, since loss of Akt1 activity assessed through its GSK-3alpha/beta substrate by pharmacological blockade of the phosphatidylinositide-3-kinase pathway or the gene silencing of Akt1 expression prevents neuronal protection during mGluRI activation. Closely coupled to the robust neuroprotection by mGluRI activation are the inhibitory phosphorylation and prevention of caspase 3 cleavage of the Forkhead transcription factor FOXO3a, the down-regulation of Bim expression, and the protection of beta-catenin by Akt1 against phosphorylation and degradation to promote its translocation from the cytoplasm to the nucleus and allow it to assist with a "pro-survival" cellular program. Further insight into the cellular mechanisms that determine neuronal protection by the metabotropic glutamate system will foster the successful therapeutic development of mGluRs for neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16719794      PMCID: PMC2040240          DOI: 10.2174/156720206776875830

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  58 in total

1.  Neurodegeneration and energy metabolism: from chemistry to clinics.

Authors:  F Blandini; K H Braunewell; D Manahan-Vaughan; F Orzi; P Sarti
Journal:  Cell Death Differ       Date:  2004-04       Impact factor: 15.828

Review 2.  Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury.

Authors:  Z Z Chong; F Li; K Maiese
Journal:  Histol Histopathol       Date:  2005-01       Impact factor: 2.303

3.  Akt activation by growth factors is a multiple-step process: the role of the PH domain.

Authors:  A Bellacosa; T O Chan; N N Ahmed; K Datta; S Malstrom; D Stokoe; F McCormick; J Feng; P Tsichlis
Journal:  Oncogene       Date:  1998-07-23       Impact factor: 9.867

Review 4.  Calcium homeostasis following traumatic neuronal injury.

Authors:  John T Weber
Journal:  Curr Neurovasc Res       Date:  2004-04       Impact factor: 1.990

5.  The inhibition of glycogen synthase kinase 3beta by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Abeta peptides.

Authors:  Feng Liu; Xiaohai Gong; Guoming Zhang; Karen Marquis; Peter Reinhart; Terrance H Andree
Journal:  J Neurochem       Date:  2005-11-08       Impact factor: 5.372

6.  Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.

Authors:  José Luis Albasanz; Esther Dalfó; Isidro Ferrer; Mairena Martín
Journal:  Neurobiol Dis       Date:  2005-06-08       Impact factor: 5.996

7.  Disintegrin causes proteolysis of beta-catenin and apoptosis of endothelial cells. Involvement of cell-cell and cell-ECM interactions in regulating cell viability.

Authors:  Wen-Bin Wu; Hui-Chin Peng; Tur-Fu Huang
Journal:  Exp Cell Res       Date:  2003-05-15       Impact factor: 3.905

8.  Metabotropic glutamate receptors modulate synaptic transmission in the perforant path: pharmacology and localization of two distinct receptors.

Authors:  D Dietrich; H Beck; T Kral; H Clusmann; C E Elger; J Schramm
Journal:  Brain Res       Date:  1997-09-05       Impact factor: 3.252

9.  Metabotropic glutamate receptors prevent programmed cell death through the modulation of neuronal endonuclease activity and intracellular pH.

Authors:  A M Vincent; M TenBroeke; K Maiese
Journal:  Exp Neurol       Date:  1999-01       Impact factor: 5.330

10.  FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines.

Authors:  Andrew Sunters; Silvia Fernández de Mattos; Marie Stahl; Jan J Brosens; Georgia Zoumpoulidou; Catherine A Saunders; Paul J Coffer; René H Medema; R Charles Coombes; Eric W-F Lam
Journal:  J Biol Chem       Date:  2003-10-03       Impact factor: 5.157

View more
  51 in total

1.  FoxO3a changes in pyramidal neurons and expresses in non-pyramidal neurons and astrocytes in the gerbil hippocampal CA1 region after transient cerebral ischemia.

Authors:  Ki-Yeon Yoo; Seung-Hae Kwon; Choong Hyun Lee; Bingchun Yan; Joon Ha Park; Ji Hyeon Ahn; Jung Hoon Choi; Taek Geun Ohk; Jun Hwi Cho; Moo-Ho Won
Journal:  Neurochem Res       Date:  2011-11-12       Impact factor: 3.996

Review 2.  The "O" class: crafting clinical care with FoxO transcription factors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

3.  Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation.

Authors:  Jinling Hou; Zhao Zhong Chong; Yan Chen Shang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2010-05       Impact factor: 1.990

Review 4.  The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.

Authors:  Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

Review 5.  The Wnt signaling pathway: aging gracefully as a protectionist?

Authors:  Kenneth Maiese; Faqi Li; Zhao Zhong Chong; Yan Chen Shang
Journal:  Pharmacol Ther       Date:  2008-02-11       Impact factor: 12.310

6.  Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation.

Authors:  Miou Zhou; Wei Xu; Guanghong Liao; Xiaoning Bi; Michel Baudry
Journal:  Exp Neurol       Date:  2009-04-15       Impact factor: 5.330

7.  Enhanced tolerance against early and late apoptotic oxidative stress in mammalian neurons through nicotinamidase and sirtuin mediated pathways.

Authors:  Zhao Zhong Chong; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2008-08       Impact factor: 1.990

Review 8.  Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2018       Impact factor: 1.990

Review 9.  A "FOXO" in sight: targeting Foxo proteins from conception to cancer.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Med Res Rev       Date:  2009-05       Impact factor: 12.944

10.  Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation.

Authors:  Abigail Polter; Sufen Yang; Anna A Zmijewska; Thomas van Groen; Ji-Hye Paik; Ronald A Depinho; Stanford L Peng; Richard S Jope; Xiaohua Li
Journal:  Biol Psychiatry       Date:  2008-09-27       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.